INS and Hyperglycemia: These findings indicated that administration of W-0373-mGLP-1 protected the mice from hyperglycemia and other symptoms by inhibiting glucagon secretion and β-cell apoptosis as well as improving insulin sensitivity, which were consistent with the known effects of GLP-1 [7,8].